Biblio
Export 239 results:
[ Author![(Asc)](https://www.j-alz.com/sites/all/modules/contrib/biblio/misc/arrow-asc.png)
Filters: First Letter Of Last Name is B [Clear All Filters]
“Default Mode Network Lateralization and Memory in Healthy Aging and Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1223-1234, 2018.
, “Tau Proteins Cross the Blood-Brain Barrier.”, J Alzheimers Dis, vol. 55, no. 1, pp. 411-419, 2017.
, “Entorhinal Perfusion Predicts Future Memory Decline, Neurodegeneration, and White Matter Hyperintensity Progression in Older Adults.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1711-1725, 2021.
, “Interaction Between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1553-62, 2016.
, “Cortical Amyloid Burden Differences Across Empirically-Derived Mild Cognitive Impairment Subtypes and Interaction with APOE ɛ4 Genotype.”, J Alzheimers Dis, vol. 52, no. 3, pp. 849-61, 2016.
, “Total MRI Small Vessel Disease Burden Correlates with Cognitive Performance, Cortical Atrophy, and Network Measures in a Memory Clinic Population.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1485-1497, 2018.
, “The Oral Iron Chelator, Deferasirox, Reverses the Age-Dependent Alterations in Iron and Amyloid-β Homeostasis in Rat Brain: Implications in the Therapy of Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 3, pp. 681-93, 2016.
, “Genetic Variations in ABCA7 Can Increase Secreted Levels of Amyloid-β40 and Amyloid-β42 Peptides and ABCA7 Transcription in Cell Culture Models.”, J Alzheimers Dis, vol. 53, no. 3, pp. 875-92, 2016.
, “Multi-Faceted Role of Melatonin in Neuroprotection and Amelioration of Tau Aggregates in Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1481-1493, 2018.
, “Cognitive Stimulation Modulates Platelet Total Phospholipases A2 Activity in Subjects with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 50, no. 4, pp. 957-62, 2016.
, “Effect of a Comprehensive Intervention on Plasma BDNF in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 1, pp. 37-43, 2017.
, “The Continuing Failure of Bexarotene in Alzheimer's Disease Mice.”, J Alzheimers Dis, 2015.
, “Heavy Metals Exposure and Alzheimer's Disease and Related Dementias.”, J Alzheimers Dis, vol. 76, no. 4, pp. 1215-1242, 2020.
, “Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment.”, Neuron, vol. 74, no. 3, pp. 467-74, 2012.
, “Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 3, pp. 977-988, 2018.
, “Extracellular Vesicles Containing P301L Mutant Tau Accelerate Pathological Tau Phosphorylation and Oligomer Formation but Do Not Seed Mature Neurofibrillary Tangles in ALZ17 Mice.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1207-1217, 2016.
, “Characterization of Music and Photograph Evoked Autobiographical Memories in People with Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 2, pp. 693-706, 2018.
, “The Impact of Music on the Self in Dementia.”, J Alzheimers Dis, vol. 61, no. 3, pp. 827-841, 2018.
, “Unusual Clinical Presentations Challenging the Early Clinical Diagnosis of Creutzfeldt-Jakob Disease.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1051-1065, 2018.
, “Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings.”, J Alzheimers Dis, vol. 50, no. 2, pp. 465-76, 2016.
, “Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol.”, J Alzheimers Dis, vol. 96, no. 2, pp. 683-693, 2023.
, “Tailored and Adaptive Computerized Cognitive Training in Older Adults at Risk for Dementia: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 60, no. 3, pp. 889-911, 2017.
, “Porphyromonas gingivalis (W83) Infection Induces Alzheimer's Disease-Like Pathophysiology in Obese and Diabetic Mice.”, J Alzheimers Dis, vol. 82, no. 3, pp. 1259-1275, 2021.
, “General Practice Clinical Data Help Identify Dementia Hotspots: A Novel Geospatial Analysis Approach.”, J Alzheimers Dis, vol. 61, no. 1, pp. 125-134, 2018.
, “Epitomic Characterization of the Specificity of the Anti-Amyloid Aβ Monoclonal Antibodies 6E10 and 4G8.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1235-1244, 2018.
,